Pregnenolone
Pregnenolone is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target glycine receptor subunit beta, nuclear receptor subfamily 1 group I member 2, glycine receptor subunit alpha-1, transient receptor potential cation channel subfamily M member 3, glycine receptor subunit alpha-2, and transient receptor potential cation channel subfamily M member 1.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
32 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Schizophrenia | D012559 | EFO_0000692 | F20 | 1 | 3 | 1 | 1 | 2 | 7 |
Major depressive disorder | D003865 | EFO_0003761 | F22 | 2 | 3 | — | 2 | — | 6 |
Psychotic disorders | D011618 | F20.81 | — | 2 | — | 1 | 1 | 4 | |
Alcoholism | D000437 | EFO_0003829 | F10.1 | 2 | — | — | 1 | — | 3 |
Bipolar disorder | D001714 | EFO_0000289 | F30.9 | — | — | — | 3 | — | 3 |
Substance-related disorders | D019966 | EFO_0003890 | F13 | — | — | — | 1 | — | 1 |
Indications Phases 3
No data
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Post-traumatic stress disorders | D013313 | EFO_0001358 | F43.1 | 1 | 2 | — | — | 1 | 4 |
Traumatic brain injuries | D000070642 | S06 | — | 2 | — | — | 1 | 3 | |
Autistic disorder | D001321 | EFO_0003758 | F84.0 | — | 2 | — | — | — | 2 |
Substance withdrawal syndrome | D013375 | EFO_0005800 | — | 1 | — | — | — | 1 | |
Low back pain | D017116 | HP_0003419 | M54.5 | — | 1 | — | — | — | 1 |
Marijuana abuse | D002189 | EFO_0007191 | F12 | — | 1 | — | — | — | 1 |
Menopause | D008593 | EFO_0003922 | N95 | 1 | 1 | — | — | — | 1 |
Perimenopause | D047648 | 1 | 1 | — | — | — | 1 | ||
Autism spectrum disorder | D000067877 | F84.0 | — | 1 | — | — | — | 1 | |
Fatigue | D005221 | HP_0012378 | R53.83 | — | 1 | — | — | — | 1 |
Show 3 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | 2 | — | — | — | — | 2 | ||
Alcoholic intoxication | D000435 | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | PREGNENOLONE |
INN | pregnenolone |
Description | Pregnenolone is a 20-oxo steroid that is pregn-5-ene substituted by a beta-hydroxy group at position 3 and an oxo group at position 20. It has a role as a human metabolite and a mouse metabolite. It is a 20-oxo steroid, a C21-steroid and a 3beta-hydroxy-Delta(5)-steroid. It derives from a hydride of a pregnane. |
Classification | Small molecule |
Drug class | steroids (not prednisolone derivatives) |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC(=O)[C@H]1CC[C@H]2[C@@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C |
Identifiers
PDB | — |
CAS-ID | 145-13-1 |
RxCUI | 114052 |
ChEMBL ID | CHEMBL253363 |
ChEBI ID | 16581 |
PubChem CID | 8955 |
DrugBank | DB02789 |
UNII ID | 73R90F7MQ8 (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
GLRB
GLRB
NR1I2
NR1I2
GLRA1
GLRA1
TRPM3
TRPM3
GLRA2
GLRA2
TRPM1
TRPM1
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 8,374 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
13 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more